CWG
ABBV icon

Cornerstone Wealth Group’s AbbVie ABBV Stock Holding History

Cornerstone Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.4M Buy
70,337
+718
+1% +$159K 0.93% 22
2025
Q4 		$15.9M Buy
69,619
+2,037
+3% +$464K 1.09% 19
2025
Q3 		$15.6M Buy
67,582
+278
+0.4% +$56.6K 1.06% 18
2025
Q2 		$12.5M Buy
67,304
+1,571
+2% +$292K 0.94% 22
2025
Q1 		$13.8M Sell
65,733
-3,051
-4% -$593K 1.14% 20
2024
Q4 		$12.2M Buy
68,784
+1,127
+2% +$207K 1% 18
2024
Q3 		$13.4M Buy
67,657
+126
+0.2% +$23.5K 1.11% 20
2024
Q2 		$11.6M Buy
67,531
+1,458
+2% +$242K 1.03% 22
2024
Q1 		$12M Buy
66,073
+37,203
+129% +$6.41M 1.11% 21
2023
Q4 		$4.47M Buy
28,870
+26,689
+1,224% +$3.89M 0.64% 45
2023
Q3 		$325K Buy
2,181
+190
+10% +$27.9K 0.06% 119
2023
Q2 		$268K Sell
1,991
-33,396
-94% -$4.9M 0.05% 126
2023
Q1 		$5.64M Sell
35,387
-434
-1% -$66.4K 1% 26
2022
Q4 		$5.79M Sell
35,821
-304
-0.8% -$46.6K 1.09% 26
2022
Q3 		$4.85M Buy
36,125
+3,516
+11% +$505K 1.07% 31
2022
Q2 		$4.99M Sell
32,609
-4,046
-11% -$618K 1.05% 30
2022
Q1 		$5.94M Sell
36,655
-5,685
-13% -$826K 1.09% 20
2021
Q4 		$5.73M Buy
+42,340
New +$5M 0.98% 29
2019
Q3 		– Sell
-33,052
Closed -$2.4M – 123
2019
Q2 		$2.4M Buy
33,052
+15,666
+90% +$1.23M 0.65% 42
2019
Q1 		$1.4M Buy
+17,386
New +$1.42M 0.35% 68

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cornerstone Wealth Group's ABBV Position: Q1 2026 in Review

Cornerstone Wealth Group increased its AbbVie (ABBV) stake by 1% in Q1 2026, buying an estimated $159K and bringing the position to 70,337 shares worth $14.4M. The position accounts for 0.93% of the portfolio, ranked #22.

Cornerstone Wealth Group first reported a position in ABBV in Q1 2019 and has held it in 20 quarters since. The position peaked at $15.9M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Cornerstone Wealth Group held 70,337 shares of AbbVie worth $14.4M as of Q1 2026.
  • Cornerstone Wealth Group bought 718 AbbVie shares in Q1 2026, an estimated $159K.
  • AbbVie made up 0.93% of Cornerstone Wealth Group's portfolio in Q1 2026, its #22 holding.
  • Cornerstone Wealth Group first reported a position in AbbVie in Q1 2019 and has held it in 20 quarters since.
  • Cornerstone Wealth Group's AbbVie position peaked at $15.9M in Q4 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Cornerstone Wealth Group's 13F filing for Q1 2026, filed 22 Apr 2026.